Vertex Enters Into Agreement to Acquire Alpine Immune Sciences

Contributed by: Business Wire

Logo

Tags

Health

Clinical Trials

Research

Pharmaceutical

Science

Biotechnology

Alpine

More Like This

Vertex Provides Updates on Multiple Kidney Programs at the American Society of Nephrology (ASN) Annual Kidney Week Congress

Vertex Advances Inaxaplin (VX-147) into Phase 3 Portion of Adaptive Phase 2/3 Clinical Trial for the Treatment of APOL1-Mediated Kidney Disease

PR Newswire associated0

BioVaxys Acquires All Intellectual Property, Immunotherapeutics Platform Technology, and Clinical Stage Assets of the Former IMV Inc.

PR Newswire associated0

Alkermes plc Announces Agreement to Sell Athlone, Ireland Facility to Novo Nordisk

Vertex Appoints Michel Lagarde to its Board of Directors

AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease

PR Newswire associated0

Alkermes plc Completes Sale of Athlone, Ireland Facility to Novo Nordisk

Vertex Announces Advancements of Suzetrigine (VX-548) in Acute and Neuropathic Pain